CERULEAN PHARMA INC - 15708Q105

Detailed investor-level table based on 13F positions.

Shareholders (13F)

Quarter: Q2 2017 · Compare: Q1 2017
13D/13G major owners: Ownership tab.
Methodology: Market value and % of portfolio use SEC reported VALUE ($000). For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received. Details.
Rows: 0
Investor History Status Shares held Market value ($000) % of portfolio Previous % Rank Change in shares % change in shares Source Date reported
Kingsview Wealth Management, LLC History No change 10,722 5 0.0% 0.01% 1 0 0.0% Q2 2017 Jan 29, 2020